There are an estimated 333 million cases of sexually transmitted infections (STIs) in adults aged 15-49, of which 16 million are in Europe.
It is estimated that, worldwide, there are 270 million cases of infections caused by HUMAN PAPILOMA VIRUS (HPV). Of these, 27 million have genital warts, another 27 million low-grade lesions, 1.5 million high-grade lesions and 0.4 million cervical carcinomas.
The PAPILOMAVIRUS HUMAN (HPV) are double-stranded DNA viruses with a genome of approximately 8,000 base pairs.
Based on their association with cervical cancer and precursor lesions, Human Papillomavirus can be grouped into high and low risk types. The analytical method that we put at your disposal detects and performs the typing of the different high-risk HPV viruses with a very high sensitivity.
High-risk HPVs include types: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68.
Within the group of Low-risk Human Papilloma Virus, the types 6 and 11 associated with condyloma acuminatum stand out. Among the high risk, types 16 and 18, associated with cervical carcinoma, stand out. Within this group, type 16 is probably the one that occurs most frequently and is associated with squamous cell cancer, followed by type 18, preferably associated with adenocarcinoma.
Sexually acquired HPV can produce several types of lesions depending on the type of Human Papillomavirus involved:
The lesions associated with types 6 and 11 can range from latent infections without clinical expression, to subclinical infections, to anogenital warts that do not evolve into neoplasms. In contrast, high-risk HPV types (mainly types 16 and 18) are the cause of long-acting active infections, with change in infected cells, and lead to genital neoplasias
Note that our Cytogenetics / Molecular Biology Section has specialists with proven experience who will always inform and provide all support for the interpretation of the results obtained. The sample is very simple to take and during this summer we have a special rate for this test.